Laboratory Biomarker Analysis + Pharmacological Study + Eribulin Mesylate for carcinoma, transitional cell

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Aug 2006: Trial registered, NCT00365157
  2. 23 Oct 2006: Trial started, NCT00365157

The trials

NCT00365157: Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

State
Under way
Phase
Phase 1 and Phase 2
People
168 taking part
Started
23 Oct 2006
Primary completion
9 Jul 2025
Arms
Treatment (eribulin mesylate)
Results
Posted on the registry
  1. 17 Aug 2006: Trial registered
  2. 23 Oct 2006: Trial started
  3. 9 Sep 2026: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.